We are live on
!
Find out more
ACM
Arlington Capital Management Portfolio holdings
AUM
$161M
1-Year Est. Return
38.38%
This Fund
S&P 500
This Quarter
Est. Return
+0.39%
1 Year Est. Return
+38.38%
3 Year Est. Return
+153.55%
5 Year Est. Return
+294.8%
10 Year Est. Return
+509.37%
AUM
$149M
AUM Growth
+$9.62M
(+6.9%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
7.49%
Top 10 Holdings %
Top 10 Hldgs %
83.49%
Holding
33
New
3
Increased
18
Reduced
5
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$2.35M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$2.16M |
| 3 |
iShares US Healthcare Providers ETF
IHF
|
+$1.72M |
| 4 |
iShares US Transportation ETF
IYT
|
+$1.5M |
| 5 |
iShares S&P India Nifty 50 Index Fund
INDY
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$1.93M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$1.36M |
| 3 |
FirstEnergy
FE
|
+$1.31M |
| 4 |
Procter & Gamble
PG
|
+$510K |
| 5 |
Philip Morris
PM
|
+$429K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 12.45% |
| 2 | Healthcare | 11.83% |
| 3 | Industrials | 7.84% |
| 4 | Financials | 1.18% |
| 5 | Real Estate | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Biotechnology ETF
IBB
$9.45B
| $22.5M | 15.05% |
180,192
+18,009
| +11% | +$2.16M |
|
|
2
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
| $19.5M | 13.06% |
447,379
+48,272
| +12% | +$2.35M |
|
|
3
iShares US Healthcare Providers ETF
IHF
$1.22B
| $17.9M | 11.99% |
620,270
+63,500
| +11% | +$1.72M |
|
|
4
iShares S&P India Nifty 50 Index Fund
INDY
$558M
| $14.3M | 9.56% |
472,551
+49,173
| +12% | +$1.48M |
|
|
5
iShares US Transportation ETF
IYT
$2.28B
| $13.8M | 9.26% |
377,736
+39,168
| +12% | +$1.5M |
|
6
Ulta Beauty
ULTA
$21.8B
| $9.64M | 6.46% |
61,837
+5,851
| +10% | +$899K |
|
7
Bath & Body Works
BBWI
$3.97B
| $8.94M | 5.99% |
128,110
+11,596
| +10% | +$832K |
|
8
Southwest Airlines
LUV
$21.7B
| $7.29M | 4.88% |
214,678
+19,097
| +10% | +$747K |
|
9
BioMarin Pharmaceuticals
BMRN
$11.9B
| $6.98M | 4.67% |
50,369
+5,380
| +12% | +$667K |
|
10
Vertex Pharmaceuticals
VRTX
$123B
| $3.82M | 2.56% |
30,797
+2,696
| +10% | +$340K |
|
11
XPO
XPO
$23.4B
| $3.7M | 2.48% |
235,857
+20,572
| +10% | +$334K |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $3.66M | 2.45% |
31,287
+2,718
| +10% | +$311K |
|
|
MDVN
13
DELISTED
MEDIVATION, INC.
MDVN
| $3.65M | 2.44% |
63,298
+5,608
| +10% | +$346K |
|
14
Amgen
AMGN
$209B
| $3.2M | 2.15% |
20,665
+1,876
| +10% | +$301K |
|
|
MPT
15
Medical Properties Trust
MPT
$2.84B
| $1.47M | 0.99% |
112,407
+1,232
| +1% | +$17.2K |
|
16
Cohen & Steers REIT and Preferred and Income Fund
RNP
$989M
| $1.43M | 0.96% |
81,641
+8,196
| +11% | +$153K |
|
17
Bank of America Series L
BAC.PRL
$3.93B
| $1.35M | 0.91% |
1,216
-4
| -0.3% | -$4.59K |
|
18
iShares Mortgage Real Estate ETF
REM
$549M
| $1.15M | 0.77% |
27,099
-53
| -0.2% | -$2.45K |
|
|
HTS
19
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $1.11M | 0.74% |
68,218
-641
| -0.9% | -$11.5K |
|
20
Banco Bilbao Vizcaya Argentaria
BBVA
$142B
| $1.05M | 0.7% |
111,452
+29,782
| +36% | +$288K |
|
21
BlackRock Enhanced Captial and Income Fund
CII
$964M
| $825K | 0.55% |
+56,230
| New | +$862K |
|
22
Banco Santander Chile
BSAC
$16.1B
| $717K | 0.48% |
102,239
+59,830
| +141% | +$1.28M |
|
|
FLY
23
DELISTED
Fly Leasing Limited
FLY
| $366K | 0.25% |
23,282
-653
| -3% | -$9.97K |
|
|
ATCO
24
DELISTED
Atlas Corp.
ATCO
| $354K | 0.24% |
18,758
-179
| -0.9% | -$3.53K |
|
25
Apple
AAPL
$4.97T
| $229K | 0.15% |
+7,316
| New | +$234K |
|
Similar funds
FPWM
GWA
RCWM
IC
PCC
MWM
CF
CCW
Arlington Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Arlington Capital Management held 33 positions worth $149M, up 6.9% from $140M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Arlington Capital Management deployed $11.2M of net new capital in Q2 2015, opening 3 new positions and adding to 18 existing holdings. Its largest new stake was BlackRock Enhanced Captial and Income Fund: 56,230 shares worth $825K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was HATTERAS FINANCIAL CORP, an estimated $11.5K trimmed.
- Arlington Capital Management's largest Q2 2015 buy was BlackRock Enhanced Captial and Income Fund: 56,230 shares worth $825K.
- Arlington Capital Management added most to Xtrackers Harvest CSI 300 China A-Shares ETF in Q2 2015, an estimated $2.35M increase.
- Arlington Capital Management's biggest Q2 2015 reduction was HATTERAS FINANCIAL CORP, cutting an estimated $11.5K.
- Arlington Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2015, selling an estimated $1.93M.
- Arlington Capital Management's ten largest holdings make up 83% of its $149M portfolio in Q2 2015.
- Arlington Capital Management opened 3 new positions and closed 6 in Q2 2015.
- Arlington Capital Management's portfolio value rose 6.9% quarter-over-quarter to $149M.
Based on Arlington Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.